IFNG and cancer: The IFN-γ-related signature was negatively associated with cancer immunity cycles, immunotherapy-predicted pathways, and immune infiltrating cells in the TCGA BLCA dataset, Xiangya real-world cohort, and IMvigor210 cohort.